Cross-species genomic and epigenomic landscape of retinoblastoma

Oncotarget

Volumn 4, Issue 6, 2013, Pages 844-859

  Benavente, Claudia A ^a   McEvoy, Justina D ^a   Finkelstein, David ^a   Wei, Lei ^a   Kang, Guolian ^a   Wang, Yong Dong ^a   Neale, Geoffrey ^a   Susan Ragsdale, ^a   Valentine, Virginia ^a   Bahrami, Armita ^a   Temirov, Jamshid ^a   Pounds, Stanley ^a   Zhang, Jinghui ^a   Dyer, Michael A ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Epigenetics; RB1; Retinoblastoma

Indexed keywords

DNA; DOUBLE STRANDED DNA;

ANEUPLOIDY; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENOMIC INSTABILITY; GENOMICS; HISTOPATHOLOGY; HUMAN; MOUSE; NONHUMAN; RETINOBLASTOMA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; TRANSLATIONAL RESEARCH; TUMOR GROWTH;

ANIMALS; DISEASE MODELS, ANIMAL; EPIGENOMICS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ENGINEERING; GENOMICS; HUMANS; MICE; MICE, KNOCKOUT; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; SPECIES SPECIFICITY;

EID: 84880830430     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1051     Document Type: Article

References (39)

1. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM and Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986; 323(6089):643-646.
2. Manning AL, Longworth MS and Dyson NJ. Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev. 2010; 24(13):1364-1376.
3. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW and Cordon-Cardo C. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature. 2004; 430(7001):797-802.
4. Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC, Jr., Squire JA and Gallie BL. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008; 17(10):1363-1372.
5. Ferreira R, Naguibneva I, Pritchard LL, Ait-Si-Ali S and Harel-Bellan A. The Rb/chromatin connection and epigenetic control: opinion. Oncogene. 2001; 20(24):3128-3133.
6. Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, Ulyanov A, Wu G, Wilson M, Wang J, Brennan R, Rusch M, Manning AL, Ma J, Easton J, Shurtleff S, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 2012; 481(7381):329-334.
7. Zhang J, Schweers B and Dyer MA. The first knockout mouse model of retinoblastoma. Cell Cycle. 2004; 3(7):952-959.
8. Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, Teunisse A, Lam S, Ramos Y, Mohan A, Johnson D, Wilson M, Rodriguez-Galindo C, Quarto M, Francoz S, Mendrysa SM, et al. Inactivation of the p53 pathway in retinoblastoma. Nature. 2006; 444(7115):61-66.
9. McEvoy J, Flores-Otero J, Zhang J, Nemeth K, Brennan R, Bradley C, Krafcik F, Rodriguez-Galindo C, Wilson M, Xiong S, Lozano G, Sage J, Fu L, Louhibi L, Trimarchi J, Pani A, et al. Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. Cancer Cell. 2011; 20(2):260-275.
10. Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, Stewart C and Dyer MA. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin Cancer Res. 2005; 11(20):7569-7578.
11. Nemeth KM, Federico S, Carcaboso AM, Shen Y, Schaiquevich P, Zhang J, Egorin M, Stewart C and Dyer MA. Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma. Cancer. 2011; 117(2):421-434.
12. Brennan RC, Federico S, Bradley C, Zhang J, Flores-Otero J, Wilson M, Stewart C, Zhu F, Guy K and Dyer MA. Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a. Cancer Res. 2011; 71(12):4205-4213.
13. Fukasawa K, Wiener F, Vande Woude GF and Mai S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene. 1997; 15(11):1295-1302.
14. Norimura T, Nomoto S, Katsuki M, Gondo Y and Kondo S. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat Med. 1996; 2(5):577-580.
15. Pounds S, Cao X, Cheng C, Yang JJ, Campana D, Pui CH, Evans WE and Relling MV. Integrated analysis of pharmacologic, clinical and SNP microarray data using Projection Onto the Most Interesting Statistical Evidence with Adaptive Permutation Testing. Int J Data Min Bioinform. 2011; 5(2):143-157.
16. Kawauchi D, Robinson G, Uziel T, Gibson P, Rehg J, Gao C, Finkelstein D, Qu C, Pounds S, Ellison DW, Gilbertson RJ and Roussel MF. A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell. 2012; 21(2):168-180.
17. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998; 279(5349):349-352.
18. Laurie N, Mohan A, McEvoy J, Reed D, Zhang J, Schweers B, Ajioka I, Valentine V, Johnson D, Ellison D and Dyer MA. Changes in retinoblastoma cell adhesion associated with optic nerve invasion. Mol Cell Biol. 2009; 29(23):6268-6282.
19. McFall RC, Sery TW and Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 1977; 37(4):1003-1010.
20. Squire J, Gallie BL and Phillips RA. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet. 1985; 70(4):291-301.
21. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D and Pellman D. DNA breaks and chromosome pulverization from errors in mitosis. Nature. 2012; 482(7383):53-58.
22. Reid TW, Albert DM, Rabson AS, Russell P, Craft J, Chu EW, Tralka TS and Wilcox JL. Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst.1974; 53(2):347-360.
23. Ganem NJ, Godinho SA and Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009; 460(7252):278-282.
24. Iovino F, Lentini L, Amato A and Di Leonardo A. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts. Molecular cancer. 2006; 5:38.
25. Amato A, Lentini L, Schillaci T, Iovino F and Di Leonardo A. RNAi mediated acute depletion of retinoblastoma protein (pRb) promotes aneuploidy in human primary cells via micronuclei formation. BMC cell biology. 2009; 10:79.
26. Ono T, Fang Y, Spector DL and Hirano T. Spatial and temporal regulation of Condensins I and II in mitotic chromosome assembly in human cells. Molecular biology of the cell. 2004; 15(7):3296-3308.
27. Kenney RD and Heald R. Essential roles for cohesin in kinetochore and spindle function in Xenopus egg extracts. Journal of cell science. 2006; 119(Pt 24):5057-5066.
28. Samoshkin A, Arnaoutov A, Jansen LE, Ouspenski I, Dye L, Karpova T, McNally J, Dasso M, Cleveland DW and Strunnikov A. Human condensin function is essential for centromeric chromatin assembly and proper sister kinetochore orientation. PLoS One. 2009; 4(8):e6831.
29. McKinnon PJ and Caldecott KW. DNA strand break repair and human genetic disease. Annu Rev Genomics Hum Genet. 2007; 8:37-55.
30. Jeggo PA and Lobrich M. DNA double-strand breaks: their cellular and clinical impact? Oncogene. 2007; 26(56):7717-7719.
31. Hakem R. DNA-damage repair; the good, the bad, and the ugly. Embo J. 2008; 27(4):589-605.
32. Frappart PO, Lee Y, Lamont J and McKinnon PJ. BRCA2 is required for neurogenesis and suppression of medulloblastoma. Embo J. 2007; 26(11):2732-2742.
33. D'Angiolella V, Santarpia C and Grieco D. Oxidative stress overrides the spindle checkpoint. Cell Cycle. 2007; 6(5):576-579.
34. McBride TJ, Schneider JE, Floyd RA and Loeb LA. Mutations induced by methylene blue plus light in singlestranded M13mp2. Proc Natl Acad Sci U S A. 1992; 89(15):6866-6870.
35. Bignon YJ, Chen Y, Chang CY, Riley DJ, Windle JJ, Mellon PL and Lee WH. Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev. 1993; 7(9):1654-1662.
36. Lee WH, Murphree AL and Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature. 1984; 309(5967):458-460.
37. Squire J, Goddard AD, Canton M, Becker A, Phillips RA and Gallie BL. Tumour induction by the retinoblastoma mutation is independent of N-myc expression. Nature. 1986; 322(6079):555-557.
38. Manning AL and Dyson NJ. pRB, a tumor suppressor with a stabilizing presence. Trends in cell biology. 2011. 39. Singh NP, McCoy MT, Tice RR and Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988; 175(1):184-191.
39. Pounds S, Gao CL, Johnson RA, Wright KD, Poppleton H, Finkelstein D, Leary SE and Gilbertson RJ. A procedure to statistically evaluate agreement of differential expression for cross-species genomics. Bioinformatics. 2011; 27(15):2098-2103.